Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.326,81
-0,01%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ANI Pharmaceuticals Inc (ANIP) ANI Pharmaceuticals Inc (ANIP) Notizie

ANI Pharmaceuticals Inc

ANIP
66,74
-2,08 (-3,02%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202400:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202413:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202413:59EDGAR2Form 8-K - Current report
05/6/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:35EDGAR2Form 144 - Report of proposed sale of securities
29/5/202422:30GLOBEANI Pharmaceuticals to Present at the 2024 Jefferies Global..
24/5/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202402:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202401:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/5/202422:06EDGAR2Form 8-K - Current report
23/5/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202422:57EDGAR2Form 144 - Report of proposed sale of securities
20/5/202412:50GLOBEANI Pharmaceuticals Announces the Launch of Kionex®..
18/5/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:50EDGAR2Form 144 - Report of proposed sale of securities
16/5/202423:02EDGAR2Form 144 - Report of proposed sale of securities
16/5/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:49EDGAR2Form 144 - Report of proposed sale of securities
15/5/202422:59EDGAR2Form 144 - Report of proposed sale of securities
15/5/202401:47EDGAR2Form 144 - Report of proposed sale of securities
14/5/202422:11EDGAR2Form 8-K - Current report
13/5/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202413:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202412:55EDGAR2Form 8-K - Current report
10/5/202412:50GLOBEANI Pharmaceuticals Reports Record First Quarter 2024..
01/5/202422:30GLOBEANI Pharmaceuticals to Participate at Two Upcoming..
18/4/202422:05GLOBEANI Pharmaceuticals to Discuss First Quarter 2024 Financial..
09/4/202412:50GLOBEANI Pharmaceuticals Announces the Launch of Baclofen Oral..
04/4/202412:50GLOBEANI Pharmaceuticals Recognizes Sarcoidosis Awareness Month..
03/4/202412:50GLOBEANI Pharmaceuticals to Participate at the Piper Sandler..
27/3/202411:50GLOBEANI Pharmaceuticals Announces the Launch of Levofloxacin..
09/3/202401:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:59EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:26EDGAR2Form 144 - Report of proposed sale of securities
08/3/202403:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 144 - Report of proposed sale of securities
06/3/202423:58EDGAR2Form 144 - Report of proposed sale of securities
06/3/202423:31EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:29EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202423:00EDGAR2Form 144 - Report of proposed sale of securities
05/3/202401:18EDGAR2Form 144 - Report of proposed sale of securities
01/3/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 67,71 Min: 66,52 Max: 68,68
Chiusura: 68,82

La tua Cronologia

NASDAQ
ANIP
ANI Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network